Douglas Flora: The August Issue of AI in Precision Oncology is Here!
Douglas Flora shared on LinkedIn:
“The August Issue of AI in Precision Oncology is Here!
I’m excited to share that our latest issue is now available. It focuses entirely on the applications of artificial intelligence in the future of cancer screening. This issue covers these important advances in some detail across a number of strategies and tumors.
This article is the best I’ve found on this topic. Thank you to authors Maysaa El Zoghbi and Seth Gross for bringing your great manuscript to AI in Precision Oncology.
Please consider sharing this with the gastroenterologists in your network—it’s a must-read for anyone in the field.
Check out the complete Table of Contents here.”
Comprehensive Review of the Current State-of-the-Art in AI-Driven Colorectal Cancer Screening
Authors: Maysaa El Zoghbi and Seth Gross
Source: Douglas Flora/LinkedIn
For more posts by Douglas Flora, visit oncodaily.com
Douglas Flora is the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, overseeing clinical operations, strategic planning, and the expansion of cancer programs. He is also the co-founder of the Center for Precision Medicine; Genomic Health.
As the Editor-in-Chief of ‘AI in Precision Oncology,’ the first peer-reviewed academic journal dedicated to this field, he plays a pivotal role in advancing research. He is also an active board member of the American Cancer Society and ACCC, where he contributes to advocacy, education, and innovation within the cancer community.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023